ABSC Pure Organic CBD Oil Used in Pilot Epilepsy Study at Colorado State University
Great news out of Dr. McGrath’s lab at Colorado State University! Dr. McGrath–a veterinary neurologist at the University’s James L. Voss Teaching Hospital–conducted a double-blind pilot study using ABSC Pure Organic CBD Oil™ to look at using CBD to treat dogs with epilepsy. Calling her preliminary results “very promising,” Dr. McGrath reports that 89% of the dogs in the small pilot study showed a reduction in seizure frequency.
Sixteen dogs were enrolled in the clinical trial. Nine dogs were treated with CBD, which has 0.3 percent or less of the psychoactive component of cannabis, THC; seven dogs in a control group were treated with a placebo. The compound is not considered marijuana and can be used for research purposes based on the 2014 United States Department of Agriculture Farm Bill.Giuden, Mary. July 19, 2019. Preliminary data from CBD clinical trials ‘promising.’ News from the College of Veterinary Medicine and Biomedical Sciences. https://cvmbs.source.colostate.edu/preliminary-data-from-cbd-clinical-trials-promising/
We Care Enough To Do the Research
We are thrilled to be part of Dr. McGrath’s research, and to see these encouraging results with canine epilepsy patients. Although we have many anecdotal stories about CBD’s ability to reduce the frequency and severity of seizures, it’s important that we continue to gather clinical research and evidence. That’s why we will always support researchers like Dr. McGrath, who are leading the charge for more knowledge about CBD.
More Clinical Trials
Dr. McGrath and her colleagues at Colorado State have launched a larger clinical trial for epilepsy, and are seeking to enroll 60 dogs. You can learn more about that trial, including how to enroll, at the teaching hospital’s website. Want to learn more about other clinical trials happening with ABSC Pure Organic CBD Oil? You can visit our News & Research page for updates on all the exciting things happening with veterinary CBD research!